[go: up one dir, main page]

DD240015A5 - Verfahren zur herstellung von 2-amino-oxazolinen - Google Patents

Verfahren zur herstellung von 2-amino-oxazolinen Download PDF

Info

Publication number
DD240015A5
DD240015A5 DD85278275A DD27827585A DD240015A5 DD 240015 A5 DD240015 A5 DD 240015A5 DD 85278275 A DD85278275 A DD 85278275A DD 27827585 A DD27827585 A DD 27827585A DD 240015 A5 DD240015 A5 DD 240015A5
Authority
DD
German Democratic Republic
Prior art keywords
radical
hydrogen
lower alkyl
amino
zero
Prior art date
Application number
DD85278275A
Other languages
German (de)
English (en)
Inventor
Gerard Moinet
Michel Schaefer
Pierre Bessin
Original Assignee
�����@��������@�K@�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@��������@�K@�Kk�� filed Critical �����@��������@�K@�Kk��
Publication of DD240015A5 publication Critical patent/DD240015A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD85278275A 1984-07-05 1985-07-04 Verfahren zur herstellung von 2-amino-oxazolinen DD240015A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH326384 1984-07-05

Publications (1)

Publication Number Publication Date
DD240015A5 true DD240015A5 (de) 1986-10-15

Family

ID=4252197

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85278275A DD240015A5 (de) 1984-07-05 1985-07-04 Verfahren zur herstellung von 2-amino-oxazolinen

Country Status (14)

Country Link
EP (1) EP0167459B1 (hu)
JP (1) JPS61155375A (hu)
AT (1) ATE69222T1 (hu)
AU (1) AU579872B2 (hu)
CA (1) CA1258040A (hu)
DD (1) DD240015A5 (hu)
DE (1) DE3584584D1 (hu)
DK (1) DK302185A (hu)
ES (2) ES8700853A1 (hu)
HU (1) HU193333B (hu)
MA (1) MA20480A1 (hu)
OA (1) OA08166A (hu)
PL (1) PL254398A1 (hu)
PT (1) PT80779B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632860A1 (fr) * 1988-06-21 1989-12-22 Rolland Sa A Nouveaux medicaments antidepresseurs et les compositions pharmaceutiques en renfermant
KR100358922B1 (ko) * 1994-08-22 2003-01-24 미쯔비시 웰 파마 가부시키가이샤 벤젠화합물및그의의약으로서의용도
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
MXPA04006709A (es) 2002-01-11 2004-10-04 Sankyo Co Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen.
JP2005272453A (ja) 2004-02-24 2005-10-06 Sankyo Co Ltd アミノアルコール化合物
RU2473545C2 (ru) * 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
KR101222412B1 (ko) * 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 Ｔａａｒ1 리간드로서의 2-아미노옥사졸린
BRPI0907563A2 (pt) * 2008-02-18 2015-08-04 Hoffmann La Roche Derivados de 4,5-di-hidro-xazol-2-il amina
JP5547187B2 (ja) * 2008-07-24 2014-07-09 エフ．ホフマン−ラ ロシュ アーゲー ４，５−ジヒドロ−オキサゾール−２−イル誘導体
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
SG11201807516UA (en) 2016-03-17 2018-09-27 Hoffmann La Roche 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448M (fr) * 1963-02-27 1964-04-06 Mcneilab Inc Composé de la classe des 2-amino-5-aryl-oxazolines et compositions pharmaceutiques le contenant.
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
US4647557A (en) * 1982-12-28 1987-03-03 Gerard Moinet Novel heterocyclic derivatives bearing an amino radical, processes for their production and the pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE3584584D1 (de) 1991-12-12
ES8700853A1 (es) 1986-10-16
MA20480A1 (fr) 1986-04-01
AU579872B2 (en) 1988-12-15
EP0167459A3 (en) 1987-02-25
CA1258040A (fr) 1989-08-01
ES8705364A1 (es) 1987-05-01
EP0167459A2 (fr) 1986-01-08
HU193333B (en) 1987-09-28
PT80779B (fr) 1987-01-12
PT80779A (fr) 1985-08-01
HUT38918A (en) 1986-07-28
ES553058A0 (es) 1987-05-01
OA08166A (fr) 1987-03-31
DK302185A (da) 1986-01-06
ATE69222T1 (de) 1991-11-15
ES544926A0 (es) 1986-10-16
JPS61155375A (ja) 1986-07-15
PL254398A1 (en) 1986-06-17
AU4468185A (en) 1986-01-30
EP0167459B1 (fr) 1991-11-06
DK302185D0 (da) 1985-07-03

Similar Documents

Publication Publication Date Title
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE69613240T2 (de) N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden
DE69425273T2 (de) N-substituierte azabicycloalkanderivate als neuroleptika usw.
DE60103927T2 (de) Piperazinderivate, deren Herstellung und deren Verwendung in der Behandlung von Störungen des Zentralnervensystems
CH664567A5 (de) Aromatische carbonsaeure- und sulfonsaeureester oder -amide.
DE69111815T2 (de) Piperazinylderivate mit Affinität zu 5-HT Rezeptoren.
DD240015A5 (de) Verfahren zur herstellung von 2-amino-oxazolinen
CH616668A5 (hu)
DE69622246T2 (de) Neue Naphthamid-Derivate und ihre therapeutische Verwendung als D3-Rezeptor Agonisten
DE3342164A1 (de) Antipsychotisch wirkende benzoxazine, verfahren zu deren herstellung sowie pharmazeutische zubereitungen, die diese enthalten
DE3125471C2 (de) Piperazinderivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE69720715T2 (de) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
DE3586411T2 (de) Dopamin-antagoniste.
DE69720317T2 (de) Benzoxazole Derivate als Serotonin 5-HT3 Rezeptor partiell Aktivator
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE69311566T2 (de) Heterocyclische amine als calmodulin antagonisten
DE2633889A1 (de) Neue aminobenzocyclohepten-derivate und deren salze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
CH678322A5 (hu)
EP0431371A1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD273258A5 (de) Verfahren zur herstellung von spiroimidazolidinen
DE2314639A1 (de) Pharmakodynamisch aktive aminoalkyloximaether
DE1941534C3 (de) Hexahydroazepine und diese Verbindungen enthaltende Arzneimittel
CH616935A5 (en) Process for the preparation of chromone derivatives
DD148633A5 (de) Verfahren zur herstellung von hexahydro-1,4-oxazepinen
DE2513136B2 (de) N-(I -Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate